VistaGen Provides Update on $36 Million Strategic Financing Agreement

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/28/13 -- VistaGen Therapeutics, Inc. (OTCQB: VSTA), a biotechnology…

Continue Reading

UPDATE: VistaGen Announces $36 Million Strategic Financing Agreement

Proceeds Will Accelerate Stem Cell Technology-Based Drug Rescue, Predictive Toxicology and Drug Metabolism Programs

Continue Reading

VistaGen Announces $36 Million Strategic Financing Agreement

Proceeds Will Accelerate Stem Cell Technology-Based Drug Rescue, Predictive Toxicology and Drug Metabolism Programs

Continue Reading

VistaGen Therapeutics Announces Strategic Financing With Platinum Long Term Growth Fund

Company Also Completes Long-Term Debt Restructuring

Continue Reading